Sequential cyclophosphamide-bortezomib-dexamethasone (CyBorD) unmasks the harmful cardiac effect of dexamethasone in primary (AL) cardiac amyloidosis
29 April 2017 (00:00 - 00:00)
Organised by:
About the speaker
University Hospital Henri Mondor, Creteil (France)
29 More presentations in this session
Doctor K. Lam (Murdoch, AU)
Doctor B. Sadeh (Tel Aviv, IL)
Doctor J. da Conceicao Pedro Pais (Evora, PT)
Doctor A. Klimenko (Moscow, RU)
Access the full session
The Event
Heart Failure 2017 - 4th World Congress on Acute Heart Failure
29 April - 2 May 2017
